AstraZeneca - Digital Technology in Pharma
9
“Going beyond the pill – Can technology enhance the role of pharmaceutical products in the treatment of chronic diseases”
-
Upload
technology-ventures-event-mmubs-dbms -
Category
Documents
-
view
1.481 -
download
0
description
Transcript of AstraZeneca - Digital Technology in Pharma
“Going beyond the pill – Can technology enhance the role of pharmaceutical products in the treatment of chronic diseases”
2
The opportunity and the challengeA growing demand for healthcare
People are living longer.
Patient populations are growing in emerging markets.
Many diseases are still not well managed.
Can increased use of technology aid in delivering healthcare to populations?
A growing body of evidence on adherence!
“Increasing the effectiveness of adherence interventions may have a far greater impact on the health of the population than any improvement in specific medical treatments” WHO Report, 2003
“20% of initial scripts are never filled, and 40% to 70% of those patients who fill a script drop off therapy after four months” AZ Funded Market Research, 2005
An example of unmet need
Management of diabetic patients is approx 15% of national healthcare budget80% of this budget is spent on the downstream consequences of poor control
Access to patient information
Patient information
services and medication reminder
Sophisticated medication reminder, additional disease
management, healthcare
services and outcome reporting
Use of data to tailor
interventions to maximise the benefit of a
treatment on overall health
outcomes
How far have we moved already?
Intelligent Pharmaceuticals will help patients to take control of their illnesses and wellness.
The additional data provided by Intelligent Pharmaceuticals will help physicians to monitor their patients and adjust treatment as appropriate
Caregivers
Who Will Intelligent Pharma Benefit?
Improved adherence and increased data will help caregivers to look after the patient
Increased adherence will decrease costs for payers
Healthcare practitioner
s
Payers
Patients
“...achieving effective blood pressure control would be approximately equivalent to eliminating alldeaths from accidents, or from influenza and pneumonia combined.”
—David Cutler, Harvard University
